As of April 16, 2025, Verve Therapeutics (VERV) has a market cap of $0.44 billion USD. According to our data, Verve Therapeutics is ranked No.6099 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.44 B |
-7.58%
|
Dec 31, 2024 | $0.48 B |
-59.54%
|
Dec 29, 2023 | $1.18 B |
-27.96%
|
Dec 30, 2022 | $1.64 B |
-47.52%
|
Dec 31, 2021 | $3.12 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.70 B |
0.000 M
|
![]() USA
|
![]() Passage Bio
PASG
|
$22.93 M |
0.000 M
|
![]() USA
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
Market Cap | = | VERV Stock Price | * | VERV Shares Outstanding |
= | $4.97 | * | 88.80 M | |
= | $0.44 B |